Dechema 3D Cell Culture 2021 (Online)
Models, Applications & Translation
3D CELL CULTURE 2021 GOES ONLINE!
Due to the current development of the COVID-19 pandemic the conference will take place online now. We are very sorry not to meet you in Konzerthaus Freiburg as originally planned, but very much look forward to welcoming you to an interactive virtual event.
The online conference programme will be published soon, and registration will open again. Further information will follow as soon as possible.
The 3D Cell Culture 2021 conference will focus on advanced and predictive 3D cell culture models for the understanding of diseases and substance testing. This includes complex systems like multi-cell type models, multi-organ and microphysiological systems.
The successful development and application of 3D cell culture relies on innovative enabling technologies like new devices, printing and imaging technologies, analytical tools, high-throughput and automatisation.
A key question is the successful translation of models to clinical and industrial applications. What are the success stories? How can 3D models be used to predict therapies or to investigate infectious diseases? Where are the hurdles, also in the regulatory context?
In addition to scientific presentations, the exhibition will showcase practical applications, products and solutions and further stimulate discussion between researchers, solution providers and users.
The topics of the 3D Cell Culture 2021 are as follow:
BIOLOGY: ADVANCED CELL CULTURE MODELS
• Advanced models for substance testing
• Innovative disease models
• Multi-cell type models
• Deviations from 3D models to the patient
TECHNOLOGY: MICROPHYSIOLOGICAL SYSTEMS, BIOMANUFACTURING AND ANALYSIS
• Microphysiological and multi-organ technologies
• New devices for 3D cell culture
• Advanced imaging technologies
• High-throughput and automation
• 3D printing
• Bioinformatics, systems biology, modelling
APPLICATIONS: CLINICAL AND INDUSTRIAL TRANSLATION
• 3D models for therapies
• Prediction of drug efficacy and safety
• Precision medicine
• Translation of models to solutions
• Regulatory aspects
• 3D models to investigate infectious diseases
Start date: 5 May 2021
End date: 7 May 2021